Ruxolitinib
- PDF / 181,285 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 100 Downloads / 186 Views
1 S
Varicella zoster virus clinical reactivation: case report In a study comprising 25 patients, one patient [age and sex not stated] was described, who experienced clinical reactivation of Varicella zoster virus during treatment with ruxolitinib for Ph-negative myeloproliferative neoplasms [route, dosage, duration of treatment to reaction onset and outcome not stated]. Rumi E, et al. Evaluation of virus-specific T cell responses in patients affected with myeloproliferative neoplasms treated with ruxolitinib. Blood 134 (Suppl. 1): abstr. 1660, 803446569 13 Nov 2019. Available from: URL: http://doi.org/10.1182/blood-2019-127994 [abstract]
0114-9954/20/1787-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 18 Jan 2020 No. 1787
Data Loading...
